These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 37872476)

  • 21. Characterization of virulence factors and antibiotic resistance pattern of uropathogenic
    Kumar M N; Bhat S; Bhat K A; Saralaya V; Shenoy Mulki S
    F1000Res; 2022; 11():1163. PubMed ID: 36531258
    [No Abstract]   [Full Text] [Related]  

  • 22. Antimicrobial Resistance, Virulence Factor-Encoding Genes, and Biofilm-Forming Ability of Community-Associated Uropathogenic
    Arafa SH; Alshehri WA; Organji SR; Elbanna K; Obaid NA; Aldosari MS; Asiri FH; Ahmad I; Abulreesh HH
    Pol J Microbiol; 2022 Sep; 71(3):325-339. PubMed ID: 36048880
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quinolone-resistant uropathogenic
    Sultan AM; Amer GF; Nabiel Y
    J Med Microbiol; 2021 Oct; 70(10):. PubMed ID: 34665111
    [No Abstract]   [Full Text] [Related]  

  • 24. Effect of sub-minimal inhibitory concentration ceftazidime on the pathogenicity of uropathogenic Escherichia coli.
    Feng W; Zhang L; Yuan Q; Wang Y; Yao P; Xia P; Sun F
    Microb Pathog; 2021 Feb; 151():104748. PubMed ID: 33484810
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel perspective on eugenol as a natural anti-quorum sensing molecule against Serratia sp.
    Frikha F; Jardak M; Aifa S; Mnif S
    Microb Pathog; 2024 Apr; 189():106576. PubMed ID: 38382626
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ciprofloxacin resistance in uropathogenic Escherichia coli isolates causing community-acquired urinary infections in Brasília, Brazil.
    Moreira da Silva RCR; de Oliveira Martins Júnior P; Gonçalves LF; de Paulo Martins V; de Melo ABF; Pitondo-Silva A; de Campos TA
    J Glob Antimicrob Resist; 2017 Jun; 9():61-67. PubMed ID: 28419868
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Distribution of genes encoding adhesins and biofilm formation capacity among Uropathogenic
    Kadry AA; Al-Kashef NM; El-Ganiny AM
    Afr Health Sci; 2020 Mar; 20(1):238-247. PubMed ID: 33402912
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antimicrobial and cytotoxic synergism of biocides and quorum-sensing inhibitors against uropathogenic Escherichiacoli.
    Capper-Parkin KL; Nichol T; Smith TJ; Lacey MM; Forbes S
    J Hosp Infect; 2023 Apr; 134():138-146. PubMed ID: 36801429
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Uropathogenic
    Alfuraiji N; Al-Hamami A; Ibrahim M; Rajab HK; Hussain BW
    J Med Life; 2022 May; 15(5):650-654. PubMed ID: 35815089
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Distribution of virulence genes and phylogenetics of uropathogenic Escherichia coli among urinary tract infection patients in Addis Ababa, Ethiopia.
    Dadi BR; Abebe T; Zhang L; Mihret A; Abebe W; Amogne W
    BMC Infect Dis; 2020 Feb; 20(1):108. PubMed ID: 32033541
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ciprofloxacin, amoxicillin, and aminoglycosides stimulate genetic and phenotypic changes in uropathogenic Escherichia coli strains.
    Adamus-Białek W; Wawszczak M; Arabski M; Majchrzak M; Gulba M; Jarych D; Parniewski P; Głuszek S
    Virulence; 2019 Dec; 10(1):260-276. PubMed ID: 30938219
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genomic epidemiology and antibiotic susceptibility profiling of uropathogenic
    Salamzade R; McElheny CL; Manson AL; Earl AM; Shaikh N; Doi Y
    mSphere; 2023 Oct; 8(5):e0018423. PubMed ID: 37581436
    [No Abstract]   [Full Text] [Related]  

  • 33. Phenotypic Assessment of Clinical Escherichia coli Isolates as an Indicator for Uropathogenic Potential.
    Shea AE; Frick-Cheng AE; Smith SN; Mobley HLT
    mSystems; 2022 Dec; 7(6):e0082722. PubMed ID: 36445110
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular Analysis of Uropathogenic E.coli Isolates from Urinary Tract Infections.
    Valadbeigi H; Esmaeeli E; Ghafourian S; Maleki A; Sadeghifard N
    Infect Disord Drug Targets; 2019; 19(3):322-326. PubMed ID: 30421685
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Virulence factors of uropathogenic Escherichia coli of urinary tract infections and asymptomatic bacteriuria in children.
    Yun KW; Kim HY; Park HK; Kim W; Lim IS
    J Microbiol Immunol Infect; 2014 Dec; 47(6):455-61. PubMed ID: 24064288
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Study of class 1 integrons and plasmid profile among multiple drug resistant uropathogenic Escherichia coli.
    Javed S; Mirani ZA; Pirzada ZA
    Pak J Pharm Sci; 2020 Nov; 33(6):2643-2649. PubMed ID: 33867342
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Snapshot of Phylogenetic Groups, Virulence, and Resistance Markers in
    Cristea VC; Gheorghe I; Czobor Barbu I; Popa LI; Ispas B; Grigore GA; Bucatariu I; Popa GL; Angelescu MC; Velican A; Marutescu L; Popa M; Chifiriuc MC; Popa IM
    Biomed Res Int; 2019; 2019():5712371. PubMed ID: 31236408
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fructose furoic acid ester: An effective quorum sensing inhibitor against uropathogenic Escherichia coli.
    Vinothkannan R; Muthu Tamizh M; David Raj C; Adline Princy S
    Bioorg Chem; 2018 Sep; 79():310-318. PubMed ID: 29800818
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Discovery of New Genes Involved in Curli Production by a Uropathogenic Escherichia coli Strain from the Highly Virulent O45:K1:H7 Lineage.
    Nhu NTK; Phan MD; Peters KM; Lo AW; Forde BM; Min Chong T; Yin WF; Chan KG; Chromek M; Brauner A; Chapman MR; Beatson SA; Schembri MA
    mBio; 2018 Aug; 9(4):. PubMed ID: 30131362
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biofilm and multidrug resistance in uropathogenic Escherichia coli.
    Mittal S; Sharma M; Chaudhary U
    Pathog Glob Health; 2015 Feb; 109(1):26-9. PubMed ID: 25605466
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.